Late breakers - ABBV-RGX-314: A one-time in-office gene therapy for the treatment of diabetic retinopathy and the prevention of DME, PDR & other vision threatening complications
Diabetic Retinal Diseases and Retinal Detachment - Outcomes of the HORNBILL Study: Phase 1/2a Trial Investigating BI 764524 in Patients With Diabetic Macular Ischemia
Advancements in Geographic Atrophy (GA): Current and Emerging Therapies - Fas Inhibition with ONL1204 for the Treatment of GA Secondary to AMD: Results from a Phase 1b Study